CHCO(CHCO)
CHCO
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $325M | $335M |
| Low | $325M | $334M |
| High | $326M | $336M |
| EBITDA Avg | $158M | $163M |
| Low | $158M | $163M |
| High | $158M | $163M |
| EBIT Avg | $144M | $149M |
| Low | $144M | $148M |
| High | $144M | $149M |
| Net Income Avg | $130M | $136M |
| Low | $129M | $134M |
| High | $131M | $139M |
| EPS Avg | $9.05 | $9.50 |
| Low | $8.99 | $9.31 |
| High | $9.10 | $9.67 |
| Analysts (Rev / EPS) | 3 / 4 | 3 / 4 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $81M | $82M | $83M | $82M | $83M | $85M | $85M |
| Low | $81M | $82M | $83M | $81M | $83M | $84M | $85M |
| High | $81M | $82M | $83M | $82M | $84M | $85M | $86M |
| EBITDA Avg | $39M | $40M | $40M | $40M | $41M | $41M | $42M |
| Low | $39M | $40M | $40M | $40M | $40M | $41M | $41M |
| High | $39M | $40M | $41M | $40M | $41M | $41M | $42M |
| EBIT Avg | $36M | $36M | $37M | $36M | $37M | $37M | $38M |
| Low | $36M | $36M | $37M | $36M | $37M | $37M | $38M |
| High | $36M | $36M | $37M | $36M | $37M | $38M | $38M |
| Net Income Avg | $32M | $33M | $33M | $32M | $34M | $35M | $35M |
| Low | $31M | $33M | $33M | $32M | $33M | $35M | $35M |
| High | $32M | $33M | $33M | $33M | $34M | $35M | $35M |
| EPS Avg | $2.22 | $2.30 | $2.33 | $2.27 | $2.35 | $2.43 | $2.45 |
| Low | $2.20 | $2.28 | $2.32 | $2.26 | $2.34 | $2.42 | $2.44 |
| High | $2.23 | $2.32 | $2.34 | $2.28 | $2.36 | $2.45 | $2.47 |
| Analysts (Rev / EPS) | 3 / 3 | 3 / 3 | 2 / 1 | 1 / 1 | 2 / 1 | 2 / 1 | 1 / 1 |